Trial intelligence / Profile preview

Probiotic adjuncts in tailored triple therapy for Helicobacter pylori eradication

TCTR20141209001Completed

Sponsor
Suranaree University of Technology
Start
Jun 2014
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Trial of lactobacillus delbrueckii in Helicobacter pylori infection, sponsored by Suranaree University of Technology. Primary endpoint: Helicobacter pylori eradication rate. Started Jun 2014; status: completed.

02

Drugs

lactobacillus delbrueckii
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on TCTR20141209001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20141209001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call